论文部分内容阅读
目的:探讨西医药剂肾衰竭路径对于慢性肾衰竭患者的应用效果。方法:通过对我院2013年7月到2014年1月期间入院的慢性肾衰竭患者48例作为主要研究对象,把此48例患者随机分为观察组和对照组;两组均为24例,观察组采用西医药剂肾衰竭临床路径治疗,对照组采用西医药剂常规治疗,两组患者进行临床效果对比,并对结果进行分析对比;以P<0.05具有统计学意义。结果:观察组患者的治疗总有效率达到83.33%明显高于对照组总有效率50.00%,具有统计学意义(P<0.05)。结论:对于慢性肾衰竭病人采用西医药剂肾衰竭路径进行治疗,具有有效率高,住院时间短的临床效果,值得临床推广。
Objective: To investigate the effect of western medicine path of renal failure on patients with chronic renal failure. Methods: Forty-eight patients with chronic renal failure who admitted to our hospital from July 2013 to January 2014 were selected as the main study subjects. The 48 patients were randomly divided into observation group and control group. Both groups were 24 cases, The observation group was treated with the clinical pathway of western medicine renal failure, while the control group was treated with western medicine routinely. The clinical effects of the two groups were compared, and the results were analyzed and compared; P <0.05 was considered statistically significant. Results: The total effective rate of the observation group was 83.33%, which was significantly higher than that of the control group (50.00%), with statistical significance (P <0.05). Conclusion: The treatment of patients with chronic renal failure by Western medicine pathways of renal failure has the clinical effect of high efficiency and short hospital stay, worthy of clinical promotion.